Breaking News

Valeant To Acquire Aesthetic Device Maker

December 16, 2013

Solta Medical is company behind Fraxel, Thermage and others.

Valeant Pharmaceuticals has entered into a definitive agreement to acquire all of the outstanding common stock of skin aesthetics device maker Solta Medical, Inc for approximately $250 million. The deal is expected to close in the first quarter of 2014.

Solta designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications.  Solta's products include the Thermage CPT system that provides non-invasive treatment options using radiofrequency energy for skin tightening, the Fraxel repair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, the Clear + Brilliant system to improve skin texture and help prevent the signs of aging skin, and the Liposonix system that destroys unwanted fat cells resulting in waist circumference reduction.  Solta's total revenue were approximately $145 million last year.

"The acquisition of Solta will bring tremendous value to Valeant's current aesthetic portfolio and together with our previous acquisitions, will create the broadest aesthetic portfolio in the industry," stated J. Michael Pearson, chairman and CEO of Valeant.  "Solta's leading aesthetic devices are a natural fit with Valeant's facial injectables, professional skin care products and physician dispensed products and will establish Valeant in a strong leadership position as we continue to build our presence in the aesthetic market.  Moreover, this transaction will further enhance our ability to offer dermatologists and plastic surgeons the most comprehensive aesthetic product offering."

According to Mark Sieczkarek, chairman of the board and interim CEO of Solta Medical, Valeant “has a proven track record of successfully integrating a number of major acquisitions into their portfolio and has established a significant presence in the aesthetics market.  The addition of Solta's industry leading brands and global sales organization creates a very compelling platform for future growth in the medical aesthetic segment.  Our entire team looks forward to executing a smooth transition of our operations into the Valeant organization."

Related End-User Markets:

blog comments powered by Disqus
  • Senior Skin Care

    Senior Skin Care

    Christine Esposito, Associate Editor||July 19, 2016
    McCord Research and Product Quest Manufacturing roll out new hospital-grade skin care kits for seniors to use at home.

  • An Antioxidant Arsenal

    An Antioxidant Arsenal

    July 11, 2016
    BioRewind is Dermarché Labs' new anti-aging regimen that delivers broad-spectrum antioxidant protection against free radicals

  • Enter Éclair

    Enter Éclair

    Christine Esposito, Associate Editor||July 5, 2016
    A new naturals line rolls out in Rite Aid stores nationwide.

  • Sustainability is Omnipresent

    Sustainability is Omnipresent

    Christine Esposito , Associate Editor||July 1, 2016
    Industry stakeholders convene in New York City for Organic Monitor’s annual event

  • Perceived Perfection

    Perceived Perfection

    Christine Esposito, Associate Editor||July 1, 2016
    From primers to pressed powders, facial cosmetics help create the illusion of a flawless complexion.

  • Preserve & Serve

    Preserve & Serve

    Melissa Meisel , Associate Editor||July 1, 2016
    Suppliers with innovative preservatives provide staying power for formulations.